RBC Europe’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.8M | Buy |
48,285
+895
| +2% | +$33.4K | 0.09% | 85 |
|
|
2022
Q1 | $2.1M | Buy |
47,390
+1,280
| +3% | +$56.7K | 0.09% | 83 |
|
|
2021
Q4 | $1.96M | Sell |
46,110
-878
| -2% | -$37.3K | 0.09% | 85 |
|
|
2021
Q3 | $2.04M | Buy |
46,988
+2,531
| +6% | +$110K | 0.08% | 106 |
|
|
2021
Q2 | $1.9M | Buy |
44,457
+2,520
| +6% | +$108K | 0.09% | 112 |
|
|
2021
Q1 | $1.62M | Buy |
41,937
+270
| +0.6% | +$10.4K | 0.09% | 111 |
|
|
2020
Q4 | $1.5M | Buy |
41,667
+3,845
| +10% | +$138K | 0.09% | 112 |
|
|
2020
Q3 | $1.45M | Buy |
37,822
+7,125
| +23% | +$272K | 0.1% | 104 |
|
|
2020
Q2 | $1.08M | Buy |
30,697
+1,580
| +5% | +$55.5K | 0.08% | 119 |
|
|
2020
Q1 | $950K | Buy |
29,117
+14,545
| +100% | +$475K | 0.09% | 106 |
|
|
2019
Q4 | $659K | Buy |
14,572
+630
| +5% | +$28.5K | 0.06% | 138 |
|
|
2019
Q3 | $567K | Buy |
13,942
+1,340
| +11% | +$54.5K | 0.06% | 150 |
|
|
2019
Q2 | $542K | Buy |
12,602
+1,000
| +9% | +$43K | 0.05% | 152 |
|
|
2019
Q1 | $445K | Sell |
11,602
-4,050
| -26% | -$155K | 0.05% | 158 |
|
|
2018
Q4 | $553K | Buy |
15,652
+140
| +0.9% | +$4.95K | 0.07% | 141 |
|
|
2018
Q3 | $597K | Buy |
15,512
+1,544
| +11% | +$59.4K | 0.07% | 144 |
|
|
2018
Q2 | $457K | Buy |
13,968
+840
| +6% | +$27.5K | 0.05% | 166 |
|
|
2018
Q1 | $359K | Buy |
13,128
+2,625
| +25% | +$71.7K | 0.04% | 185 |
|
|
2017
Q4 | $260K | Hold |
10,503
| – | – | 0.03% | 219 |
|
|
2017
Q3 | $306K | Buy |
+10,503
| New | +$306K | 0.04% | 200 |
|